Evidence map›Paper›PMID 29065798›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2017

Microphysiologic systems in female reproductive biology.

Alexandria N Young, Georgette Moyle-Heyrman, J Julie Kim, Joanna E Burdette

Abstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Organoid technology in female reproductive biomedicine.Reproductive biology and endocrinology : RB&E · 2020
    Review
  7. Review
  8. Review
  9. Review
  10. Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandria N Young1 College of Pharmacy, University of Illinois, Chicago, IL 60607, USA.
Georgette Moyle-Heyrman2 College of Science & Technology, University of Wisconsin - Green Bay, Green Bay, WI 54311, USA.
J Julie Kim3 Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Joanna E Burdette1 College of Pharmacy, University of Illinois, Chicago, IL 60607, USA.

Funding

Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic SystemUH3TR001207 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2014 to 2016
$4.9M
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeuticsF30CA217079 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YOUNG, ALEXANDRIA · 2017 to 2020
$184k
NCATS NIH HHS UH3 TR001207NCI NIH HHS F30 CA217079
6 · The paper itself

Abstract

Microphysiologic systems (MPS), including new organ-on-a-chip technologies, recapitulate tissue microenvironments by employing specially designed tissue or cell culturing techniques and microfluidic flow. Such systems are designed to incorporate physiologic factors that conventional 2D or even 3D systems cannot, such as the multicellular dynamics of a tissue-tissue interface or physical forces like fluid sheer stress. The female reproductive system is a series of interconnected organs that are necessary to produce eggs, support embryo development and female health, and impact the functioning of non-reproductive tissues throughout the body. Despite its importance, the human reproductive tract has received less attention than other organ systems, such as the liver and kidney, in terms of modeling with MPS. In this review, we discuss current gaps in the field and areas for technological advancement through the application of MPS. We explore current MPS research in female reproductive biology, including fertilization, pregnancy, and female reproductive tract diseases, with a focus on their clinical applications. Impact statement This review discusses existing microphysiologic systems technology that may be applied to study of the female reproductive tract, and those currently in development to specifically investigate gametes, fertilization, embryo development, pregnancy, and diseases of the female reproductive tract. We focus on the clinical applicability of these new technologies in fields such as assisted reproductive technologies, drug testing, disease diagnostics, and personalized medicine.

Indexed as

Cell Culture TechniquesEmbryonic DevelopmentFemaleGenital Diseases, FemaleGenitalia, FemaleHumansMicrofluidicsPregnancyReproductive Techniques, Assistedfemale reproductive tractmicrofluidic systemsMicrophysiologic systemsorgan on a chippersonalized medicinereproductive biology

Identifiers

PMID29065798
PMCPMC5786365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.